儿童结核病临床实践指南的现状与思考

doi:10.3969/j.issn.1000-6621.2020.10.004

中国防痨杂志 ›› 2020, Vol. 42 ›› Issue (10): 1025-1028.doi: 10.3969/j.issn.1000-6621.2020.10.004

儿童结核病临床实践指南的现状与思考

王泽明, 孙琳, 申阿东()

100045 北京,国家儿童医学中心首都医科大学附属北京儿童医院儿科学国家重点学科国家呼吸系统疾病临床医学研究中心儿科重大疾病研究教育部重点实验室儿童呼吸道感染性疾病研究北京市重点实验室北京市儿科研究所呼吸疾病研究室

收稿日期:2020-08-05 出版日期:2020-10-10 发布日期:2020-10-15
通信作者: 申阿东 E-mail:shenad16@hotmail.com
基金资助:
“十三五”国家科技重大专项(2018ZX10103001-003)

Current status and thinking of clinical practice guidelines of tuberculosis in children

WANG Ze-ming, SUN Lin, SHEN A-dong()

National Center for Children’s Health, Beijing Children’s Hospital, Capital Medical University, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Laboratory of Pediatric Respiratory Diseases, Beijing Pediatric Research Institute, Beijing 100045, China

Received:2020-08-05 Online:2020-10-10 Published:2020-10-15
Contact: SHEN A-dong E-mail:shenad16@hotmail.com

摘要/Abstract

摘要：

儿童结核病仍然是一种发病率和死亡率较高的传染病,为了遏制结核病,多个国家或组织相继发布了一些儿童结核病管理临床实践指南。但这些已经发布的指南的质量良莠不齐。只有高质量的指南才具有更好的指导作用。为了促进这些指南的应用和未来指南制订的规范化、科学化、透明化,笔者分析了已发布指南的发布特征、质量和内容现状,阐述了目前存在的问题及改进策略。

关键词: 儿童, 结核, 实践指南, 评价研究, 思考

Abstract:

Tuberculosis (TB) remains a infection disease which causes relatively higher morbidity and mortality in children. In order to reduce childhood TB, a number of clinical practice guidelines for the management of tuberculosis in children with variable qualities have been published by different countries or organizations, only these wtih high qualities provide a better guidance. In order to promote the application of these clinical practice guidelines in children and improve the standardization, science and transparency of the formulation of the clinical practice guidelines in the further, this article analyzed the current status of the characteristics, quality and recommendations of published clinical practice guidelines, pointed out the existing limitations and propose improvement strategies.

Key words: Child, Tuberculosis, Practice guideline, Evaluation studies, Thinking

王泽明, 孙琳, 申阿东. 儿童结核病临床实践指南的现状与思考[J]. 中国防痨杂志, 2020, 42(10): 1025-1028. doi: 10.3969/j.issn.1000-6621.2020.10.004

WANG Ze-ming, SUN Lin, SHEN A-dong. Current status and thinking of clinical practice guidelines of tuberculosis in children[J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1025-1028. doi: 10.3969/j.issn.1000-6621.2020.10.004

参考文献 22

[1]	World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019.
[2]	Jenkins HE, Yuen CM, Rodriguez CA, et al. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis, 2017,17(3):285-295. doi: 10.1016/S1473-3099(16)30474-1. doi: 10.1016/S1473-3099(16)30474-1 URL pmid: 27964822
[3]	Schaaf HS. Diagnosis and management of multidrug-resistant tuberculosis in children: a practical approach. Indian J Pediatr, 2019,86(8):717-724. doi: 10.1007/s12098-018-02846-8. doi: 10.1007/s12098-018-02846-8 URL pmid: 30656560
[4]	Wang M, Liu F, Li Q, et al. Quality assessment of guidelines for the management of Mycobacterium tuberculosis infection in children. Int J Tuberc Lung Dis, 2020,24(3):287-294. doi: 10.5588/ijtld.19.0224. doi: 10.5588/ijtld.19.0224 URL pmid: 32228758
[5]	Voss LM, Australasian Subgroup in Paediatric Infectious Disease of the Australasian Society for Infectious Diseases, Australasian Paediatric Respiratory Group. Management of tuberculosis in children. J Paediatr Child Health, 2000,36(6):530-536. doi: 10.1046/j.1440-1754.2000.00565.x. doi: 10.1046/j.1440-1754.2000.00565.x URL pmid: 11115026
[6]	Mellado Peña MJ, Santiago García B, Baquero-Artigao F, et al. Tuberculosis treatment for children: An update. An Pediatr (Barc), 2018, 88(1):52.e1-52.e12. doi: 10.1016/j.anpedi.2017.05.013. doi: 10.1016/j.anpedi.2017.05.013 URL
[7]	Canadian Tuberculosis Committee (CTC). Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep, 2008,34(ACS-6):1-13. URL pmid: 18979589
[8]	Lange C, Abubakar I, Alffenaar JW, et al. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J, 2014,44(1):23-63. doi: 10.1183/09031936.00188313. doi: 10.1183/09031936.00188313 URL pmid: 24659544
[9]	Jiang M, Guan WJ, Fang ZF, et al. A Critical Review of the Quality of Cough Clinical Practice Guidelines. Chest, 2016,150(4):777-788. doi: 10.1016/j.chest.2016.04.028. doi: 10.1016/j.chest.2016.04.028 URL pmid: 27164291
[10]	张悦. 我国临床实践指南评价指标体系构建研究. 武汉: 华中科技大学, 2016. doi: 10.7666/d.D01074532.
[11]	World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization, 2018.
[12]	National Institute for Health and Care Excellence. Tuberculosis. London: National Institute for Health and Care Excellence, 2016.
[13]	World Health Organization. The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance. Geneva: World Health Organization, 2016.
[14]	World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update. Geneva: World Health Organization, 2016.
[15]	Santin M, García-García JM, Domínguez J, et al. Guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection. Enferm Infecc Microbiol Clin, 2016, 34(5): 303.e1-13. doi: 10.1016/j.eimc.2015.11.022. doi: 10.1016/j.eimc.2015.11.022 URL
[16]	World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: World Health Organization, 2014.
[17]	World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. Geneva: World Health Organization, 2013.
[18]	World Health Organization. WHO consolidated guidelines on tuberculosis, module 4: treatment-drug-resistant tuberculosis treatment. Geneva: World Health Organization, 2020.
[19]	Galli L, Lancella L, Garazzino S, et al. Recommendations for treating children with drug-resistant tuberculosis. Pharmacol Res, 2016,105:176-182. doi: 10.1016/j.phrs.2016.01.020. doi: 10.1016/j.phrs.2016.01.020 URL pmid: 26821118
[20]	World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization, 2019.
[21]	丁泓帆, 杨楠, 邓围, 等. WHO指南制定的基本原则和方法. 中国循证医学杂志, 2016,16(4):471-477. doi: 10.7507/1672-2531.20160072.
[22]	解染, 陈耀龙, 陈昊, 等. 循证指南制定中患者价值观和偏好的研究方法. 中国循证医学杂志, 2015,15(5):586-591. doi: 10.7507/1672-2531.20150097.

儿童结核病临床实践指南的现状与思考

Current status and thinking of clinical practice guidelines of tuberculosis in children

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 22

相关文章 15

编辑推荐

Metrics

本文评价

友情链接

[1]	刘晓莉, 雷丽梅, 郭周莉, 黄殷, 徐静, 赵霞, 王燕, 付莉. 结核病患者产生病耻感与领悟社会支持的相关性研究[J]. 中国防痨杂志, 2020, 42(9): 1002-1008.
[2]	中国防痨协会学术工作委员会《中国防痨杂志》编辑委员会. 抗结核药品固定剂量复合制剂的临床使用专家共识[J]. 中国防痨杂志, 2020, 42(9): 885-893.
[3]	靳鸿建. 我国县级结核病防治服务体系建设及防治工作亟需加强——一位老防痨工作者的意见和建议[J]. 中国防痨杂志, 2020, 42(9): 896-902.
[4]	张灿有, 夏辉, 成君. Ⅱ级生物安全柜在结核病实验室中的检测及报告要求[J]. 中国防痨杂志, 2020, 42(9): 903-909.
[5]	周林, 刘二勇, 孟庆琳, 陈明亭, 周新华, 高微微, 林明贵, 谢汝明. 《WS 288—2017 肺结核诊断》标准实施后肺结核诊断质量评估分析[J]. 中国防痨杂志, 2020, 42(9): 910-915.
[6]	刘二勇, 王前, 周林, 张国钦, 张修磊, 马永成, 杨枢敏, 王毳, 孟庆琳, 陈明亭, 林明贵, 屠德华. 我国部分地区病原学检测阴性肺结核诊断质量现状分析[J]. 中国防痨杂志, 2020, 42(9): 916-920.
[7]	孟庆琳, 李进岚, 林定文, 马永成, 侯双翼, 刘年强, 周林. 结核病防治从业人员对新的结核病标准相关知识知晓情况调查分析[J]. 中国防痨杂志, 2020, 42(9): 921-925.
[8]	王前, 周林, 刘二勇, 赵雁林, 李涛, 陈明亭, 杨丽佳, 王嘉. 我国县级结核病定点医疗机构结核病诊断能力现况调查研究[J]. 中国防痨杂志, 2020, 42(9): 926-930.
[9]	李婷, 何金戈, 苏茜, 李京, 李运葵, 高文凤, 高媛, 杨文. 结核菌素试验在四川省布拖县HIV感染/AIDS患者中筛查结核感染的价值[J]. 中国防痨杂志, 2020, 42(9): 931-936.
[10]	李运葵, 何金戈, 苏茜, 李婷, 李京, 高文凤, 杨文, 毛光玉. 结核病症状筛查在四川省布拖县HIV感染/AIDS患者中发现结核病患者的价值[J]. 中国防痨杂志, 2020, 42(9): 937-941.
[11]	苏茜, 夏勇, 逯嘉, 王丹霞, 何金戈. 2009—2018年四川省0~14 岁儿童肺结核流行特征分析[J]. 中国防痨杂志, 2020, 42(9): 942-947.
[12]	邓亚丽, 张天华, 刘卫平, 张宏伟, 马煜, 李鹏. 2014—2018年陕西省肺结核发病的时空聚集性分析[J]. 中国防痨杂志, 2020, 42(9): 948-955.
[13]	董晓, 赵珍, 刘年强, 王森路, 崔燕. 2009—2017年新疆维吾尔自治区老年肺结核发现特征分析[J]. 中国防痨杂志, 2020, 42(9): 956-961.
[14]	马廷龙, 韩毅, 程序, 刘志东. 超声抗结核药品电导入联合化疗对胸壁结核的疗效观察[J]. 中国防痨杂志, 2020, 42(9): 968-972.
[15]	南海, 张芸, 杨新婷, 段鸿飞. GeneXpert MTB/RIF对骨关节结核诊断价值的Meta分析[J]. 中国防痨杂志, 2020, 42(9): 973-980.